Under a translational point of view, PA analogues have been developed such as BESpm, BENSpm, and DENSpm have been developed which augment intracellular levels of both SAT1 and SMOX, hence leading to PAs depletion ultimately resulting in tumor-selective cytotoxicity (Casero et al., 2018). This evidence concerns the gene SAT1 and neoplasm.